Who invested in Labrys Biologics?
Labrys Biologics's investors include Canaan, InterWest Partners, Sofinnova Investments and venBio Partners.
2013
$15MVenture$31MSeries AWho invested in Labrys Biologics
Funding summaryUpdated 26 Oct 2026
$46Mraised across 2 rounds since 2012, from 2 sources
$15MVenture$31MSeries A
- Latest round
- Series A, $31MJan 2013
- Step-upi
- 2.1×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $15M Dec 2012
- Biggest round
- $31M Series A · Jan 2013
The rounds
- Jan 2013Series A$31M1 new3 returning
Reported by finsmes.comSEC filing: $15M sold, first sale Dec 2012
- Dec 2012Venture$15M3 new
Reported by sec.govSEC filing: $15M sold, first sale Dec 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Labrys Biologics
How much has Labrys Biologics raised?
Labrys Biologics has raised $46M across 2 rounds since 2012.
When did Labrys Biologics last raise?
Labrys Biologics's most recent round was a Series A of $31M in Jan 2013.
What was Labrys Biologics's biggest round?
Its most recent round, $31M in Jan 2013, is also its largest on record.
Who backed Labrys Biologics first?
Labrys Biologics's first round on record, in Dec 2012, was backed by Canaan, InterWest Partners and Sofinnova Investments.
What stage is Labrys Biologics at?
Labrys Biologics's latest named round is a Series A, in Jan 2013.
Companies like Labrys Biologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.